Chronic kidney disease trials in Italy

In Italy 43 Also abroad 798

43 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Where
Rome
Age
1 year to 17 years
People
10 worldwide
Run by
Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Bassano Del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara, Padova, Pavia, Pisa, Pordenone, Rome, Rozzano, Tradate VA, Turin
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Bologna, Brescia, Ferrara, Florence, Genoa, Milan, Monza, Palermo, Parma, Perugia, Rome, Rozzano, San Donato Milanese
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseTaking people
Kidney Stiffness Measured by Ultrasound in Patients With High Blood Pressure and Healthy Volunteers
Where
Padova
Age
18 years and over
People
240
Run by
Azienda Ospedaliera di Padova
See details and how to joinNCT07914075
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Padova
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 4Taking people
CKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease
Where
Bologna, Naples
Age
18 years and over
People
115 worldwide
Run by
Steno Diabetes Center Copenhagen
See details and how to join2023-507449-27-01 · EU 2023-507449-27-01
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Bologna, Naples
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Bologna, Florence, Genoa, Milan, Rome, Turin
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples, Palermo, Pavia, Ranica, Verona
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Bologna, Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia, Genova, Lecce, Lecco, Messina, Milan, Naples, Novara, Pavia, Peschiera del Garda, Piacenza, Pisana, Prato, Reggio Calabria, Rimini, Roma, Rome, San Giovanni Rotondo, Verona
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
No phaseNot yet taking people in Italy
DialysisBot: AI Chatbot for Hemodialysis Self-Management
Where
Molfetta
Age
18 years and over
People
40
Run by
University of Rome Tor Vergata
See details and how to joinNCT07830810
Phase 3Taking people
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Where
Brescia, Florence, Foggia, Genoa, Milan, Pavia, Pisa, Verona
Age
18 years and over
People
337 worldwide
Run by
Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01
No phaseTaking people
Physical Exercise in Patients With Chronic Kidney Disease in Hemodialysis (Pehedal-ESKD)
Where
Torre del Greco
Age
18 years and over
People
312
Run by
Ricerca Nefrocenter
See details and how to joinNCT07820514
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Alexandria, Bari, Bologna, Catania, Chieri, Como, Cosenza, Feltre, Foggia, Naples, Pavia, Pordenone, Ranica, Rome, Salerno, San Giovanni Rotondo, Sesto San Giovanni, Trieste
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Florence
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
No phaseTaking people
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
Where
Varese
Age
18 years and over
People
72 worldwide
Run by
W.L.Gore & Associates
See details and how to joinNCT05846581
No phaseTaking people
Epidemiological Evaluation Of Chronic Kidney Disease In Pediatric Patients With Inflammatory Bowel Disease
Where
Alessandria
Age
2 years to 17 years
People
600
Run by
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
See details and how to joinNCT07670988
No phaseNot yet taking people in Italy
Thyroid Hormones in CKD
Where
Ranica
Age
18 years and over
People
51
Run by
Mario Negri Institute for Pharmacological Research
See details and how to joinNCT07663773
No phaseTaking people
Impact of Trans-catheter Aortic Valve Implantation on Renal Function
Where
Roma
Age
18 years and over
People
1,000
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07626710
Phase 3Taking people
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Where
Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
Age
18 years and over
People
429 worldwide
Run by
Genexine, Inc.
See details and how to joinNCT06466785
No phaseTaking people
International (Pediatric) Peritoneal Biobank
Where
Genova, Milan, Padova
Age
1 day to 90 years
People
500 worldwide
Run by
Heidelberg University
See details and how to joinNCT01893710
No phaseTaking people
ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms
Where
Cagliari
Age
18 years and over
People
120
Run by
Azienda Ospedaliera Brotzu
See details and how to joinNCT07522008
No phaseTaking people
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Where
Milan
Age
18 years to 70 years
People
146
Run by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT06635525
Phase 3Taking people
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Where
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan, Modena, Naples, Padova, Piacenza, Roma, San Benedetto del Tronto, Terni, Torino, Verona
Age
18 years and over
People
170 worldwide
Run by
Iperboreal Pharma Srl
See details and how to joinNCT03994471
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Bergamo, Bologna, Brescia, Chieti Scalo, L'aquila, Milan, Pisa, Rome
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00